Affiliation:
1. Department of Immunology, School of Basic Medical, Central South University, Changsha 410083, China
Abstract
Natural killer (NK) cells and CD8+ T cells can clear infected and transformed cells and generate tolerance to themselves, which also prevents autoimmune diseases. Natural killer group 2 member D (NKG2D) is an important activating immune receptor that is expressed on NK cells, CD8+ T cells, γδ T cells, and a very small percentage of CD4+ T cells. In contrast, the NKG2D ligand (NKG2D-L) is generally not expressed on normal cells but is overexpressed under stress. Thus, the inappropriate expression of NKG2D-L leads to the activation of self-reactive effector cells, which can trigger or exacerbate autoimmunity. In this review, we discuss the role of NKG2D and NKG2D-L in systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), multiple sclerosis (MS), type I diabetes (T1DM), inflammatory bowel disease (IBD), and celiac disease (CeD). The data suggest that NKG2D and NKG2D-L play a pathogenic role in some autoimmune diseases. Therefore, the development of strategies to block the interaction of NKG2D and NKG2D-L may have therapeutic effects in some autoimmune diseases.
Funder
National Natural Science Foundation of China
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference138 articles.
1. The intricate relationship between autoimmunity disease and neutrophils death patterns: A love-hate story;Zhang;Apoptosis,2023
2. Tan, G., Spillane, K.M., and Maher, J. (2023). The Role and Regulation of the NKG2D/NKG2D Ligand System in Cancer. Biology, 12.
3. Origin and evolutionary malleability of T cell receptor α diversity;Giorgetti;Nature,2023
4. NK cell-based tumor immunotherapy;Zhang;Bioact. Mater.,2024
5. Designing Cancer Immunotherapies That Engage T Cells and NK Cells;Kyrysyuk;Annu. Rev. Immunol.,2023